Skip to main content

About

Aims and scope

Surgical and Experimental Pathology publishes essential research in molecular and cellular pathology, physiopathology, biomarkers of disease mechanisms, clinic-pathological entities and predictive response to therapy, with a special focus on translational approaches. It also brings together research addressing animal models, new and comparative methods, and case collections for specific regions or ethnic groups. The journal explores the pathophysiological and pathogenetic mechanisms of human disease, and aims to bridge the gap between molecular investigation and daily practice in surgical pathology.

Open access

All articles published by Surgical and Experimental Pathology are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

As authors of articles published in Surgical and Experimental Pathology you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement.

For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article-processing charges

The publication costs for Surgical and Experimental Pathology are covered by the Sociedade Brasileira de Patologia, so authors do not need to pay an article-processing charge for each article accepted for publication.

Indexing services

The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink. We are working closely with relevant indexing services including PubMed Central and Web of Science (Thomson Reuters) to ensure that articles published in Surgical and Experimental Pathology will be available in their databases when appropriate.

Peer-review policy

Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.

Surgical and Experimental Pathology operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.

Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.

Benefits of single-blind peer review
Single-blind peer review is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.

Editorial policies

All manuscripts submitted to Surgical and Experimental Pathology should adhere to BMC's editorial policies.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appeals and complaints

Authors who wish to appeal a rejection or make a complaint should follow the procedure outlined in the BMC Editorial Policies.

Citing articles in Surgical and Experimental Pathology

Articles in Surgical and Experimental Pathology should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Surg Exp Pathol [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Diagn Pathol 2009, 1:115.

1:115 refers to article 115 from Volume 1 of the journal.

Benefits of publishing with BMC

High visibility

Surgical and Experimental Pathology's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. 

Speed of publication

Surgical and Experimental Pathology offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.

Flexibility

Online publication in Surgical and Experimental Pathology gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Surgical and Experimental Pathology are included in article alerts and regular email updates. Some may be highlighted on Surgical and Experimental Pathology’s pages and on the BMC homepage.

In addition, articles published in Surgical and Experimental Pathology may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Surgical and Experimental Pathology. A list of articles recently press-released by journals published by BMC is available here.

Copyright

As an author of an article published in Surgical and Experimental Pathology you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BMC license agreement).

For further information about the advantages of publishing in a journal from BMC, please click here.

Annual Journal Metrics

  • 2023 Speed
    12 days submission to first editorial decision for all manuscripts (Median)
    130 days submission to accept (Median)

    2023 Usage 
    200,184 downloads
    22 Altmetric mentions